331 related articles for article (PubMed ID: 26573045)
1. Use of Cyclosporine Therapy in Steroid Resistant Nephrotic Syndrome (SRNS): A Review.
Shah SR; Altaf A; Arshad MH; Mari A; Noorani S; Saeed E; Mevawalla AA; Haq ZU; Faquih ME
Glob J Health Sci; 2015 Aug; 8(4):136-41. PubMed ID: 26573045
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
Ghiggeri GM; Catarsi P; Scolari F; Caridi G; Bertelli R; Carrea A; Sanna-Cherchi S; Emma F; Allegri L; Cancarini G; Rizzoni GF; Perfumo F
Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
[TBL] [Abstract][Full Text] [Related]
3. Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome.
Büscher AK; Beck BB; Melk A; Hoefele J; Kranz B; Bamborschke D; Baig S; Lange-Sperandio B; Jungraithmayr T; Weber LT; Kemper MJ; Tönshoff B; Hoyer PF; Konrad M; Weber S;
Clin J Am Soc Nephrol; 2016 Feb; 11(2):245-53. PubMed ID: 26668027
[TBL] [Abstract][Full Text] [Related]
4. Treatment of steroid resistant nephrotic syndrome in children.
Kari JA; Halawani M
Saudi J Kidney Dis Transpl; 2010 May; 21(3):484-7. PubMed ID: 20427873
[TBL] [Abstract][Full Text] [Related]
5. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children.
Gulati S; Prasad N; Sharma RK; Kumar A; Gupta A; Baburaj VP
Nephrol Dial Transplant; 2008 Mar; 23(3):910-3. PubMed ID: 18039644
[TBL] [Abstract][Full Text] [Related]
7. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Habashy D; Hodson E; Craig J
Cochrane Database Syst Rev; 2004; (2):CD003594. PubMed ID: 15106208
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Rituximab in Children With Steroid- and Cyclosporine-resistant and Steroid- and Cyclosporine-dependent Nephrotic Syndrome.
Hoseini R; Sabzian K; Otukesh H; Zafaranloo N; Panahi P; Rahimzadeh N; Nakhaie S; Akhavan Sepehi M
Iran J Kidney Dis; 2018 Jan; 12(1):27-32. PubMed ID: 29421774
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome.
Büscher AK; Kranz B; Büscher R; Hildebrandt F; Dworniczak B; Pennekamp P; Kuwertz-Bröking E; Wingen AM; John U; Kemper M; Monnens L; Hoyer PF; Weber S; Konrad M
Clin J Am Soc Nephrol; 2010 Nov; 5(11):2075-84. PubMed ID: 20798252
[TBL] [Abstract][Full Text] [Related]
10. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
Gellermann J; Ehrich JH; Querfeld U
Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
12. Therapies for steroid-resistant nephrotic syndrome.
Hodson EM; Craig JC
Pediatr Nephrol; 2008 Sep; 23(9):1391-4. PubMed ID: 18368428
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of cyclosporine a for patients with steroid-resistant nephrotic syndrome: a meta-analysis.
Li HY; Zhang X; Zhou T; Zhong Z; Zhong H
BMC Nephrol; 2019 Oct; 20(1):384. PubMed ID: 31646979
[TBL] [Abstract][Full Text] [Related]
15. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
Hibino S; Uemura O; Nagai T; Yamakawa S; Iwata N; Ito H; Nakano M; Tanaka K
Pediatr Int; 2015; 57(1):85-91. PubMed ID: 25225083
[TBL] [Abstract][Full Text] [Related]
16. Current understandings in treating children with steroid-resistant nephrotic syndrome.
Lee JM; Kronbichler A; Shin JI; Oh J
Pediatr Nephrol; 2021 Apr; 36(4):747-761. PubMed ID: 32086590
[TBL] [Abstract][Full Text] [Related]
17. Steroid resistant nephrotic syndrome: role of histopathology.
Gulati S; Sengupta D; Sharma RK; Sharma A; Gupta RK; Singh U; Gupta A
Indian Pediatr; 2006 Jan; 43(1):55-60. PubMed ID: 16465008
[TBL] [Abstract][Full Text] [Related]
18. Interventions for steroid-resistant nephrotic syndrome: a systematic review.
Habashy D; Hodson EM; Craig JC
Pediatr Nephrol; 2003 Sep; 18(9):906-12. PubMed ID: 12836096
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
Okada M; Sugimoto K; Yagi K; Yanagida H; Tabata N; Takemura T
Pediatr Int; 2007 Dec; 49(6):933-7. PubMed ID: 18045300
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Efficacy of Tacrolimus Versus Cyclosporine in Childhood Steroid-Resistant Nephrotic Syndrome.
Shah SS; Hafeez F
J Coll Physicians Surg Pak; 2016 Jul; 26(7):589-93. PubMed ID: 27504551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]